We had limited ability to adjust for cancer‐related characteristics at time of treatment (e.g., anatomic distribution of disease, number and size of measurable tumors, PD‐L1, tumor mutational burden) due to a lack of structured cancer‐related information at the time of treatment. The gene discussed is CD274; the disease is neoplasm.